Literature DB >> 10171936

Cost containment and health care reform: a study of the European Union.

B Abel-Smith1, E Mossialos.   

Abstract

This article gives a short summary of the organisation and financing of health services of the 12 Member States of the European Union. It then describes the latest developments in cost containment in each of the countries. The third section describes the new initiatives for reform in Spain, Italy, the Netherlands, Portugal and the United Kingdom. Finally, it gives a summary of the cost containment measures in the 12 countries, listing them under a set of headings. They are classified as budget control, alternatives to hospital care, cost sharing, influencing authorizing behaviour and limits on supply. The article shows the considerable convergence of policies which is developing. Overall budget control in some form is to be found in 8 of the countries. Where providers are paid by a number of different insurers, budgets are nevertheless applied to hospitals in three countries and in another only to public hospitals. Both Germany and France have used budgets to control other items of expenditure. Profits or the prices of drug companies are controlled in 8 countries and in one indirectly. Three have adopted reference price systems for drugs and another has taken powers to do so. Two have adopted or are moving towards provider markets.

Mesh:

Substances:

Year:  1994        PMID: 10171936     DOI: 10.1016/0168-8510(94)90030-2

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  10 in total

1.  The hospital of the future. Better out than in? Alternatives to acute hospital care.

Authors:  M Hensher; N Fulop; J Coast; E Jefferys
Journal:  BMJ       Date:  1999-10-23

2.  Parallel imports of pharmaceuticals in the European Union.

Authors:  J Darbà; J Rovira
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

3.  The impact of therapeutic reference pricing on innovation in cardiovascular medicine.

Authors:  Desmond Sheridan; Jim Attridge
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

4.  Drug reimbursement: indicators of inappropriate resource allocation.

Authors:  Bernard Bégaud; Ulf Bergman; Hans-Georg Eichler; Hubert G M Leufkens; Peter J Meier
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

5.  [Costs and fees in health care. Evaluation and assessment by cardiological patients].

Authors:  D Jäger; H Baberg; J Kugler
Journal:  Med Klin (Munich)       Date:  1998-05-15

6.  Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Bruce Carleton; Robert J Glynn; Jerry Avorn
Journal:  BMJ       Date:  2004-02-24

7.  Pay for performance for hospitals.

Authors:  Tim Mathes; Dawid Pieper; Johannes Morche; Stephanie Polus; Thomas Jaschinski; Michaela Eikermann
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

8.  Impact of payment system change from per-case to per-diem on high severity patient's length of stay.

Authors:  Sung-In Jang; Chung Mo Nam; Sang Gyu Lee; Tae Hyun Kim; Sohee Park; Eun-Cheol Park
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

9.  Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke.

Authors:  A Semplicini; V Benetton; L Macchini; A Realdi; R Manara; C Carollo; E Parotto; V Mascagna; M Leoni; L A Calò; A C Pessina; F Tosato
Journal:  Emerg Med J       Date:  2008-07       Impact factor: 2.740

10.  Can European Countries Improve Sustainability of Health Care Financing through Patient Cost-Sharing?

Authors:  Marzena Tambor; Milena Pavlova; Stanisława Golinowska; Wim Groot
Journal:  Front Public Health       Date:  2015-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.